©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPodocytopathias, syndromal; differential diagnosis

Summary

Short information

A comprehensive differential diagnostic panel for Podocytopathies, syndromal, containing 32 genes according to the clinical suspicion

ID
PP9112
Number of loci
Locus typeCount
Gen 13
Accredited laboratory test
Examined sequence length
0,0 kb (Core-/Core-canditate-Genes)
32,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Loci

Gen

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ARHGDIA615NM_001185077.3AR
COL4A45073NM_000092.5AD, AR
COL4A55058NM_000495.5XL
CTNS1203NM_001031681.3AR
GLA1290NM_000169.3XL
INF23750NM_022489.4AD
KANK22556NM_001136191.3AR
LMX1B1188NM_002316.4AR
PAX21254NM_003987.5AD
SGPL11721NM_003901.4AR
TTC21B3951NM_024753.5AR
WT11569NM_024426.6AD
XPO53615NM_020750.3AR

Informations about the disease

Clinical Comment

illness_ClinicalComment_PP9112

 

Synonyms
  • ...ad nomenclature: depending on 1. publication/quotation -> either designated as FSGS or SRNS
  • Alias: Focal Segmental GlomeruloSklerosis, FSGS
  • Alias: Steroid-Resistant Nephrotic Syndrome, SRNS
  • Allelic: Blood group, Raph (CD151)
  • Allelic: Charcot-Marie-Tooth disease, dominant intermediate E (INF2)
  • Allelic: Deafness, AD 17 (MYH9)
  • Allelic: Hemolytic uremic syndrome, atypical, susceptibility to, 7 (DGKE)
  • Allelic: Multiple system atrophy, susceptibility to (COQ2)
  • Allelic: Nail-patella syndrome (LMX1B)
  • Allelic: Ovarian dysgenesis 6 (NUP107)
  • Allelic: Palmoplantar keratoderma and woolly hair (KANK2)
  • Allelic: Short-rib thoracic dysplasia 4 with/-out polydactyly (TTC21B)
  • Allelic: Ventriculomegaly with cystic kidney disease (CRB2)
  • Alport syndrome 1, XL (COL4A5)
  • Alport syndrome 2, AR (COL4A3)
  • Alport syndrome 2, AR (COL4A4)
  • Alport syndrome 3, AD (COL4A3)
  • Coenzyme Q10 deficiency, primary, 1 (COQ2)
  • Coenzyme Q10 deficiency, primary, 3 (PDSS2)
  • Coenzyme Q10 deficiency, primary, 6 (COQ6)
  • Congenital disorder of glycosylation, type Ia (PMM2)
  • Congenital disorder of glycosylation, type Ik (ALG1)
  • Duane retraction syndrome 3 (MAFB)
  • End-stage renal disease, nondiabetic, susceptibility to (APOL1)
  • Epidermolysis bullosa of hands + feet (ITGB4)
  • Epidermolysis bullosa simplex 7, with nephropathy + deafness (CD151)
  • Epidermolysis bullosa, junctional, non-Herlitz type (ITGB4)
  • Epidermolysis bullosa, junctional, with pyloric atresia (ITGB4)
  • Epilepsy, progressive myoclonic 4, with/-out renal failure (SCARB2)
  • Focal segmental glomerulosclerosis 10 (LMX1B)
  • Focal segmental glomerulosclerosis 8 (ANLN)
  • Focal segmental glomerulosclerosis 9 (CRB2)
  • Focal segmental glomerulosclerosis [genereviews] (ARHGAP24)
  • Galloway-Mowat syndrome 1 (WDR73)
  • Galloway-Mowat syndrome 2, XL (LAGE3)
  • Galloway-Mowat syndrome 3 (OSGEP)
  • Galloway-Mowat syndrome 4 (TP53RK)
  • Galloway-Mowat syndrome 5 (TPRKB)
  • Galloway-Mowat syndrome 7 (NUP107)
  • Galloway-Mowat syndrome 8 (NUP133)
  • Glomerulosclerosis, focal segmental, 1 (ACTN4)
  • Glomerulosclerosis, focal segmental, 2 (TRPC6)
  • Glomerulosclerosis, focal segmental, 3 (CD2AP)
  • Glomerulosclerosis, focal segmental, 4, susceptibility to (APOL1)
  • Glomerulosclerosis, focal segmental, 5 (INF2)
  • Glomerulosclerosis, focal segmental, 6 (MYO1E)
  • Glomerulosclerosis, focal segmental, 7 (PAX2)
  • Glomerulotubular nephropathy [panelapp] (FAT1)
  • Hematuria, benign familial (COL4A3)
  • Hematuria, familial benign (COL4A4)
  • Interstitial lung disease, nephrotic syndrome + epidermolysis bullosa, congenital (ITGA3)
  • Interstitial lung disease, nephrotic syndrome, epidermolysis bullosa, congenita (ITGA3)
  • Macrothrombocytopenia + granulocyte inclusions +/- nephritis or sensorineural hearing loss (MYH9)
  • Multicentric carpotarsal osteolysis syndrome (MAFB)
  • Nephronophthisis 12 (TTC21B)
  • Nephrotic syndrome (LAMA5)
  • Nephrotic syndrome (PODXL)
  • Nephrotic syndrome (TNS2)
  • Nephrotic syndrome, type 1 (NPHS1)
  • Nephrotic syndrome, type 10 (EMP2)
  • Nephrotic syndrome, type 11 (NUP107)
  • Nephrotic syndrome, type 12 (NUP93)
  • Nephrotic syndrome, type 13 (NUP205)
  • Nephrotic syndrome, type 14 (SGPL1)
  • Nephrotic syndrome, type 15 (MAGI2)
  • Nephrotic syndrome, type 16 (KANK2)
  • Nephrotic syndrome, type 17 (NUP85)
  • Nephrotic syndrome, type 18 (NUP133)
  • Nephrotic syndrome, type 19 (NUP160)
  • Nephrotic syndrome, type 2 (NPHS2)
  • Nephrotic syndrome, type 20 (TBC1D8B)
  • Nephrotic syndrome, type 21 (AVIL)
  • Nephrotic syndrome, type 22 (NOS1AP)
  • Nephrotic syndrome, type 3 (PLCE1)
  • Nephrotic syndrome, type 4 (WT1)
  • Nephrotic syndrome, type 5, with/-out ocular abnormalities (LAMB2)
  • Nephrotic syndrome, type 6 (PTPRO)
  • Nephrotic syndrome, type 7 (DGKE)
  • Nephrotic syndrome, type 8 (ARHGDIA)
  • Nephrotic syndrome, type 9 (COQ8B syn ADCK4)
  • Papillorenal syndrome (PAX2)
  • Pierson syndrome (LAMB2)
  • Schimke immunoosseous dysplasia (SMARCAL1)
  • Steroid-resistant nephrotic syndrome, nonsyndromic [genereviews] (ANKFY1)
  • Steroid-resistant nephrotic syndrome, nonsyndromic [genereviews] (GAPVD1)
  • Steroid-resistant nephrotic syndrome, nonsyndromic [genereviews] (XPO5)
  • Steroid-resistant nephrotic syndrome, syndromic [genereviews] (E2F3)
  • Steroid-resistant nephrotic syndrome, syndromic [genereviews] (MAFB)
  • Steroid-resistant nephrotic syndrome, syndromic [genereviews] (NXF5)
  • Syndactyly with/-out nephropathy [panelapp] (FAT1)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined